A reduction of salt intake to <5 g sodium chloride per day is generally advised for patients with chronic kidney disease. However, hard evidence to support this recommendation is lacking. New data from Fan et al. suggest that very strict sodium limits might be harmful in patients with renal disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
19 September 2016
In the original published version of this article, a description of the association between urinary sodium excretion and kidney failure in patients with 24 h urinary sodium excretion <3 g per day was incorrect. The description has been corrected to read “Although no association was found between 24 h urinary sodium excretion and kidney failure in patients with urinary sodium excretion >3 g per day, when 24 h urinary sodium excretion was <3g per day, a 1g per day higher urine sodium was associated with a 72% increased risk of kidney failure in patients with baseline proteinuria <1g per day, and a 39% lower risk of kidney failure in patients with baseline proteinuria ≥1g per day.” The error has been corrected in the HTML and PDF versions of the article
References
He, F. J. & MacGregor, G. A. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 378, 380–382 (2011).
O'Donnell, M. J. et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 306, 2229–2238 (2011).
Stolarz-Skrzypek, K. et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305, 1777–1785 (2011).
Fan, L., Tighiouart, H., Levey, A. S., Beck, G. J. & Sarnak, M. J. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int. http://dx.doi.org/10.1038/ki.2014.59.
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. Suppl. 2, 337–414 (2012).
Kotchen, T. A., Colwley, A. W. & Frohlich, E. D. Salt in health and disease—a delicate balance. N. Engl. J. Med. 368, 1229–1237 (2013).
Sarafidis, P. A. & Ruilope, L. M. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation? Kidney Int. 85, 536–546 (2014).
Lambers Heerspink, H. J. et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 82, 330–337 (2012).
Pruijm, M. et al. Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men. Hypertension 55, 1116–1122 (2010).
Vegter, S. et al. Sodium intake, ACE inhibition, and progression to ESRD. J. Am. Soc. Nephrol. 23, 165–173 (2012).
Acknowledgements
G.W.'s research is supported by Ambizione grants from the Swiss National Science Foundation (PZ00P3_121656 and PZ00P3_13262).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Burnier, M., Wuerzner, G. Should sodium intake be restricted in patients with CKD?. Nat Rev Nephrol 10, 363–364 (2014). https://doi.org/10.1038/nrneph.2014.88
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2014.88